25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

AURX (Nuo Therapeutics Inc) Stock Analysis
Buy, Hold or Sell?

Let's analyze Nuo Therapeutics Inc together

I guess you are interested in Nuo Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Nuo Therapeutics Inc’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Nuo Therapeutics Inc’s Price Targets

I'm going to help you getting a better view of Nuo Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Nuo Therapeutics Inc

I send you an email if I find something interesting about Nuo Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Nuo Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Nuo Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.01
Expected worth in 1 year
$0.00
How sure are you?
37.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-0.7%

For what price can you sell your share?

Current Price per Share
$1.65
Expected price per share
$1.2 - $1.76
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Nuo Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$1.65
Intrinsic Value Per Share
$-0.98 - $-1.16
Total Value Per Share
$-0.97 - $-1.15

2.2. Growth of Nuo Therapeutics Inc (5 min.)




Is Nuo Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$513.7k$893.6k-$309.6k-53.0%

How much money is Nuo Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$580.9k-$792.8k$211.9k36.5%
Net Profit Margin-183.0%-702.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Nuo Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Nuo Therapeutics Inc?

Welcome investor! Nuo Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Nuo Therapeutics Inc.

First you should know what it really means to hold a share of Nuo Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Nuo Therapeutics Inc is $1.65. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Nuo Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Nuo Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.01. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Nuo Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.01-0.6%-0.01-0.8%-0.02-1.0%-0.02-0.9%-0.01-0.8%-0.02-1.4%
Usd Book Value Change Per Share-0.01-0.5%0.00-0.2%-0.01-0.4%0.000.1%0.000.2%0.000.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-0.5%0.00-0.2%-0.01-0.4%0.000.1%0.000.2%0.000.0%
Usd Price Per Share1.40-0.81-1.28-1.12-0.94-0.57-
Price to Earnings Ratio-32.99--16.96--18.18--16.97--100.15--56.12-
Price-to-Total Gains Ratio-174.00--18.40--6.14--39.40--36.18--30.48-
Price to Book Ratio127.59-78.52-74.79-58.00-44.70-20.13-
Price-to-Total Gains Ratio-174.00--18.40--6.14--39.40--36.18--30.48-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.65
Number of shares606
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (606 shares)-1.701.55
Gains per Year (606 shares)-6.806.21
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-7-1706-4
20-14-240122
30-20-310198
40-27-3802514
50-34-4503120
60-41-5203726
70-48-5904332
80-54-6605038
90-61-7305644
100-68-8006250

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.015.00.00.0%1.026.00.03.7%1.026.00.03.7%
Book Value Change Per Share2.02.00.050.0%6.06.00.050.0%7.06.02.046.7%10.015.02.037.0%10.015.02.037.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.027.00.0%0.00.027.00.0%
Total Gains per Share2.02.00.050.0%6.06.00.050.0%7.06.02.046.7%10.015.02.037.0%10.015.02.037.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Nuo Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.008-0.003-65%-0.006-24%0.002-536%0.003-414%0.000-2080%
Book Value Per Share--0.0110.012-12%0.019-43%0.027-60%0.019-41%0.038-71%
Current Ratio--1.4551.581-8%2.105-31%3.110-53%2.518-42%1.767-18%
Debt To Asset Ratio--0.5680.590-4%0.513+11%0.463+23%3.260-83%3.748-85%
Debt To Equity Ratio--1.3161.587-17%1.153+14%1.066+23%1.036+27%0.676+95%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--64866744.00037344987.098+74%59504499.125+9%51791531.292+25%43256262.947+50%32229979.791+101%
Eps---0.011-0.012+17%-0.017+60%-0.015+45%-0.012+17%-0.023+116%
Ev To Sales Ratio--41.06828.592+44%170.968-76%188.820-78%188.820-78%117.830-65%
Free Cash Flow Per Share---0.010-0.013+22%-0.017+62%-0.017+58%-0.014+36%-0.014+31%
Free Cash Flow To Equity Per Share---0.009-0.008-10%-0.006-26%0.004-337%0.015-156%0.013-166%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.157----------
Intrinsic Value_10Y_min---0.985----------
Intrinsic Value_1Y_max---0.074----------
Intrinsic Value_1Y_min---0.072----------
Intrinsic Value_3Y_max---0.254----------
Intrinsic Value_3Y_min---0.241----------
Intrinsic Value_5Y_max---0.472----------
Intrinsic Value_5Y_min---0.436----------
Market Cap77246565.000+15%65542540.00038153951.098+72%59983128.125+9%52219458.208+26%43776486.681+50%26872614.793+144%
Net Profit Margin---1.258-1.830+45%-7.026+459%-6.021+379%-4.817+283%-7.686+511%
Operating Margin----0%-5.3430%-4.8540%-3.8830%-5.3120%
Operating Ratio--2.8123.136-10%8.131-65%7.008-60%5.606-50%6.100-54%
Pb Ratio150.369+15%127.58678.524+62%74.795+71%58.004+120%44.700+185%20.127+534%
Pe Ratio-38.883-18%-32.991-16.956-49%-18.181-45%-16.967-49%-100.146+204%-56.122+70%
Price Per Share1.650+15%1.4000.815+72%1.281+9%1.115+26%0.935+50%0.574+144%
Price To Free Cash Flow Ratio-39.368-18%-33.403-17.291-48%-18.487-45%-16.967-49%-136.036+307%-76.657+129%
Price To Total Gains Ratio-205.075-18%-174.003-18.405-89%-6.144-96%-39.400-77%-36.176-79%-30.479-82%
Quick Ratio--0.4290.408+5%0.905-53%1.015-58%0.812-47%0.500-14%
Return On Assets---0.418-0.426+2%-0.464+11%-0.390-7%-0.357-15%-0.768+84%
Return On Equity---0.967-1.161+20%-1.052+9%-0.879-9%-0.704-27%-1.045+8%
Total Gains Per Share---0.008-0.003-65%-0.006-24%0.002-536%0.003-414%0.000-2080%
Usd Book Value--513712.000584015.000-12%893677.000-43%1278499.750-60%867474.600-41%1772540.519-71%
Usd Book Value Change Per Share---0.008-0.003-65%-0.006-24%0.002-536%0.003-414%0.000-2080%
Usd Book Value Per Share--0.0110.012-12%0.019-43%0.027-60%0.019-41%0.038-71%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--64866744.00037344987.098+74%59504499.125+9%51791531.292+25%43256262.947+50%32229979.791+101%
Usd Eps---0.011-0.012+17%-0.017+60%-0.015+45%-0.012+17%-0.023+116%
Usd Free Cash Flow---490539.000-596646.000+22%-793756.500+62%-777310.667+58%-622336.733+27%-618876.370+26%
Usd Free Cash Flow Per Share---0.010-0.013+22%-0.017+62%-0.017+58%-0.014+36%-0.014+31%
Usd Free Cash Flow To Equity Per Share---0.009-0.008-10%-0.006-26%0.004-337%0.015-156%0.013-166%
Usd Market Cap77246565.000+15%65542540.00038153951.098+72%59983128.125+9%52219458.208+26%43776486.681+50%26872614.793+144%
Usd Price Per Share1.650+15%1.4000.815+72%1.281+9%1.115+26%0.935+50%0.574+144%
Usd Profit---496666.000-580926.250+17%-792859.000+60%-722239.750+45%-583400.067+17%-1074387.667+116%
Usd Revenue--394872.000341293.250+16%152131.250+160%173829.000+127%139063.200+184%165914.037+138%
Usd Total Gains Per Share---0.008-0.003-65%-0.006-24%0.002-536%0.003-414%0.000-2080%
 EOD+5 -3MRQTTM+22 -13YOY+18 -173Y+16 -195Y+15 -2010Y+17 -18

3.3 Fundamental Score

Let's check the fundamental score of Nuo Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-38.883
Price to Book Ratio (EOD)Between0-1150.369
Net Profit Margin (MRQ)Greater than0-1.258
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.429
Current Ratio (MRQ)Greater than11.455
Debt to Asset Ratio (MRQ)Less than10.568
Debt to Equity Ratio (MRQ)Less than11.316
Return on Equity (MRQ)Greater than0.15-0.967
Return on Assets (MRQ)Greater than0.05-0.418
Total2/10 (20.0%)

3.4 Technical Score

Let's check the technical score of Nuo Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.943
Ma 20Greater thanMa 501.540
Ma 50Greater thanMa 1001.413
Ma 100Greater thanMa 2001.418
OpenGreater thanClose1.600
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Nuo Therapeutics Inc

Nuo Therapeutics, Inc. operates as a regenerative therapies company that develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States. The company offers the Aurix System, which separates autologous blood to produce a platelet-based therapy for the chronic wound care market. It serves hospital outpatient wound care clinics and other private practice physicians treating chronic wounds. The company was formerly known as Cytomedix, Inc. and changed its name to Nuo Therapeutics, Inc. in November 2014. Nuo Therapeutics, Inc. was incorporated in 1998 and is based in Houston, Texas.

Fundamental data was last updated by Penke on 2025-04-27 16:04:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Nuo Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Net Profit Margin of -125.8%Β means thatΒ $-1.26 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Nuo Therapeutics Inc:

  • The MRQ is -125.8%. The company is making a huge loss. -2
  • The TTM is -183.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-125.8%TTM-183.0%+57.2%
TTM-183.0%YOY-702.6%+519.6%
TTM-183.0%5Y-481.7%+298.7%
5Y-481.7%10Y-768.6%+286.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-125.8%-92.5%-33.3%
TTM-183.0%-182.1%-0.9%
YOY-702.6%-197.2%-505.4%
3Y-602.1%-242.9%-359.2%
5Y-481.7%-348.0%-133.7%
10Y-768.6%-488.5%-280.1%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Nuo Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • -41.8% Return on Assets means thatΒ Nuo Therapeutics Inc generatedΒ $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Nuo Therapeutics Inc:

  • The MRQ is -41.8%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -42.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.8%TTM-42.6%+0.9%
TTM-42.6%YOY-46.4%+3.8%
TTM-42.6%5Y-35.7%-6.9%
5Y-35.7%10Y-76.8%+41.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.8%-11.3%-30.5%
TTM-42.6%-11.6%-31.0%
YOY-46.4%-11.5%-34.9%
3Y-39.0%-11.7%-27.3%
5Y-35.7%-12.6%-23.1%
10Y-76.8%-14.2%-62.6%
4.3.1.3. Return on Equity

Shows how efficient Nuo Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • -96.7% Return on Equity means Nuo Therapeutics Inc generated $-0.97Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Nuo Therapeutics Inc:

  • The MRQ is -96.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -116.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-96.7%TTM-116.1%+19.4%
TTM-116.1%YOY-105.2%-10.9%
TTM-116.1%5Y-70.4%-45.7%
5Y-70.4%10Y-104.5%+34.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-96.7%-15.0%-81.7%
TTM-116.1%-15.1%-101.0%
YOY-105.2%-15.1%-90.1%
3Y-87.9%-17.6%-70.3%
5Y-70.4%-18.1%-52.3%
10Y-104.5%-20.1%-84.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Nuo Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Nuo Therapeutics Inc is operatingΒ .

  • Measures how much profit Nuo Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Nuo Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-534.3%+534.3%
TTM-5Y-388.3%+388.3%
5Y-388.3%10Y-531.2%+142.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--184.5%+184.5%
TTM--287.9%+287.9%
YOY-534.3%-208.5%-325.8%
3Y-485.4%-244.6%-240.8%
5Y-388.3%-355.2%-33.1%
10Y-531.2%-475.0%-56.2%
4.3.2.2. Operating Ratio

Measures how efficient Nuo Therapeutics Inc is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Biotechnology industry mean).
  • An Operation Ratio of 2.81 means that the operating costs are $2.81 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Nuo Therapeutics Inc:

  • The MRQ is 2.812. The company is inefficient in keeping operating costs low. -1
  • The TTM is 3.136. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.812TTM3.136-0.324
TTM3.136YOY8.131-4.995
TTM3.1365Y5.606-2.470
5Y5.60610Y6.100-0.493
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8122.181+0.631
TTM3.1363.031+0.105
YOY8.1312.985+5.146
3Y7.0083.629+3.379
5Y5.6064.790+0.816
10Y6.1006.545-0.445
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Nuo Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Nuo Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Biotechnology industry mean).
  • A Current Ratio of 1.45Β means the company has $1.45 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Nuo Therapeutics Inc:

  • The MRQ is 1.455. The company is just able to pay all its short-term debts.
  • The TTM is 1.581. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.455TTM1.581-0.127
TTM1.581YOY2.105-0.524
TTM1.5815Y2.518-0.937
5Y2.51810Y1.767+0.751
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4553.588-2.133
TTM1.5813.932-2.351
YOY2.1054.272-2.167
3Y3.1104.797-1.687
5Y2.5185.817-3.299
10Y1.7676.172-4.405
4.4.3.2. Quick Ratio

Measures if Nuo Therapeutics Inc is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Quick Ratio of 0.43Β means the company can pay off $0.43 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Nuo Therapeutics Inc:

  • The MRQ is 0.429. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.408. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.429TTM0.408+0.021
TTM0.408YOY0.905-0.497
TTM0.4085Y0.812-0.404
5Y0.81210Y0.500+0.312
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4292.845-2.416
TTM0.4083.420-3.012
YOY0.9054.105-3.200
3Y1.0154.661-3.646
5Y0.8125.882-5.070
10Y0.5006.505-6.005
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Nuo Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of Nuo Therapeutics IncΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Nuo Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.57Β means that Nuo Therapeutics Inc assets areΒ financed with 56.8% credit (debt) and the remaining percentage (100% - 56.8%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Nuo Therapeutics Inc:

  • The MRQ is 0.568. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.590. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.568TTM0.590-0.022
TTM0.590YOY0.513+0.078
TTM0.5905Y3.260-2.670
5Y3.26010Y3.748-0.488
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5680.342+0.226
TTM0.5900.342+0.248
YOY0.5130.330+0.183
3Y0.4630.329+0.134
5Y3.2600.359+2.901
10Y3.7480.382+3.366
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Nuo Therapeutics Inc is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • A Debt to Equity ratio of 131.6% means that company has $1.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Nuo Therapeutics Inc:

  • The MRQ is 1.316. The company is able to pay all its debts with equity. +1
  • The TTM is 1.587. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.316TTM1.587-0.271
TTM1.587YOY1.153+0.434
TTM1.5875Y1.036+0.551
5Y1.03610Y0.676+0.360
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3160.409+0.907
TTM1.5870.427+1.160
YOY1.1530.406+0.747
3Y1.0660.436+0.630
5Y1.0360.447+0.589
10Y0.6760.498+0.178
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Nuo Therapeutics Inc generates.

  • Above 15 is considered overpriced butΒ always compareΒ Nuo Therapeutics Inc to theΒ Biotechnology industry mean.
  • A PE ratio of -32.99 means the investor is paying $-32.99Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Nuo Therapeutics Inc:

  • The EOD is -38.883. Based on the earnings, the company is expensive. -2
  • The MRQ is -32.991. Based on the earnings, the company is expensive. -2
  • The TTM is -16.956. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-38.883MRQ-32.991-5.891
MRQ-32.991TTM-16.956-16.035
TTM-16.956YOY-18.181+1.225
TTM-16.9565Y-100.146+83.190
5Y-100.14610Y-56.122-44.024
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-38.883-1.851-37.032
MRQ-32.991-2.438-30.553
TTM-16.956-3.022-13.934
YOY-18.181-3.297-14.884
3Y-16.967-4.006-12.961
5Y-100.146-6.199-93.947
10Y-56.122-6.796-49.326
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Nuo Therapeutics Inc:

  • The EOD is -39.368. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -33.403. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -17.291. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-39.368MRQ-33.403-5.965
MRQ-33.403TTM-17.291-16.112
TTM-17.291YOY-18.487+1.196
TTM-17.2915Y-136.036+118.745
5Y-136.03610Y-76.657-59.379
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-39.368-2.532-36.836
MRQ-33.403-3.298-30.105
TTM-17.291-3.938-13.353
YOY-18.487-4.309-14.178
3Y-16.967-5.461-11.506
5Y-136.036-8.408-127.628
10Y-76.657-9.443-67.214
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Nuo Therapeutics Inc is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Biotechnology industry mean).
  • A PB ratio of 127.59 means the investor is paying $127.59Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Nuo Therapeutics Inc:

  • The EOD is 150.369. Based on the equity, the company is expensive. -2
  • The MRQ is 127.586. Based on the equity, the company is expensive. -2
  • The TTM is 78.524. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD150.369MRQ127.586+22.783
MRQ127.586TTM78.524+49.062
TTM78.524YOY74.795+3.730
TTM78.5245Y44.700+33.824
5Y44.70010Y20.127+24.573
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD150.3691.813+148.556
MRQ127.5862.184+125.402
TTM78.5242.403+76.121
YOY74.7952.480+72.315
3Y58.0042.766+55.238
5Y44.7003.735+40.965
10Y20.1274.330+15.797
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,190
Total Liabilities676
Total Stockholder Equity514
 As reported
Total Liabilities 676
Total Stockholder Equity+ 514
Total Assets = 1,190

Assets

Total Assets1,190
Total Current Assets842
Long-term Assets348
Total Current Assets
Cash And Cash Equivalents 284
Net Receivables 248
Inventory 150
Other Current Assets 159
Total Current Assets  (as reported)842
Total Current Assets  (calculated)842
+/-0
Long-term Assets
Property Plant Equipment 348
Long-term Assets  (as reported)348
Long-term Assets  (calculated)348
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities578
Long-term Liabilities97
Total Stockholder Equity514
Total Current Liabilities
Accounts payable 219
Total Current Liabilities  (as reported)578
Total Current Liabilities  (calculated)219
+/- 359
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt164
Long-term Liabilities  (as reported)97
Long-term Liabilities  (calculated)164
+/- 67
Total Stockholder Equity
Total Stockholder Equity (as reported)514
Total Stockholder Equity (calculated)0
+/- 514
Other
Capital Stock5
Common Stock Shares Outstanding 46,598
Net Invested Capital 514
Net Working Capital 263
Property Plant and Equipment Gross 781



6.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-03-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
14,057
12,421
8,840
10,214
1,424
973
823
760
975
461
154
38
0
150
150
1,058
4,323
3,865
3,047
2,221
1,385
1,600
1,878
1,243
1,420
1,719
1,190
1,1901,7191,4201,2431,8781,6001,3852,2213,0473,8654,3231,0581501500381544619757608239731,42410,2148,84012,42114,057
   > Total Current Assets 
3,372
2,078
900
2,568
1,185
764
652
614
867
378
97
24
0
150
150
962
3,871
3,433
2,635
1,829
1,019
1,258
1,563
981
1,175
1,343
842
8421,3431,1759811,5631,2581,0191,8292,6353,4333,871962150150024973788676146527641,1852,5689002,0783,372
       Cash And Cash Equivalents 
2,674
1,391
331
1,923
694
147
373
250
637
185
9
17
0
148
148
665
3,445
2,878
2,051
1,250
344
583
929
366
473
684
284
2846844733669295833441,2502,0512,8783,44566514814801791856372503731476941,9233311,3912,674
       Net Receivables 
294
240
154
164
114
342
109
255
22
47
10
0
0
0
0
64
0
30
92
134
201
233
251
230
305
329
248
24832930523025123320113492300640000104722255109342114164154240294
       Inventory 
70
65
89
64
36
37
37
34
25
17
10
3
0
0
0
95
238
265
240
212
226
210
210
211
217
168
150
1501682172112102102262122402652389500031017253437373664896570
       Other Current Assets 
334
382
50
50
342
238
0
0
0
0
0
0
0
0
0
138
188
260
55
233
563
178
174
174
180
162
159
159162180174174178563233552601881380000000002383425050382334
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
84
57
14
0
0
0
96
452
432
412
392
51
341
314
262
246
376
348
3483762462623143415139241243245296000145784000000000
       Property Plant Equipment 
486
388
307
256
224
194
156
131
105
80
54
14
0
0
0
96
452
432
412
392
366
341
314
262
246
376
348
34837624626231434136639241243245296000145480105131156194224256307388486
       Goodwill 
2,079
2,079
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000002,0792,079
       Intangible Assets 
7,840
7,627
7,414
7,201
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000000000007,2017,4147,6277,840
       Other Assets 
0
0
218
188
15
15
15
15
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003331515151518821800
> Total Liabilities 
1,571
1,612
1,930
1,745
941
1,157
1,097
1,342
1,057
1,173
1,347
1,323
0
672
672
531
761
714
856
883
914
873
839
909
822
829
676
67682982290983987391488385671476153167267201,3231,3471,1731,0571,3421,0971,1579411,7451,9301,6121,571
   > Total Current Liabilities 
1,447
1,508
1,850
1,686
937
1,154
1,095
1,342
1,057
1,173
1,347
1,323
0
672
672
476
465
438
600
649
703
685
675
761
690
714
578
57871469076167568570364960043846547667267201,3231,3471,1731,0571,3421,0951,1549371,6861,8501,5081,447
       Short-term Debt 
0
0
0
0
0
0
0
0
0
331
390
410
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000410390331000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
331
390
410
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000410390331000000000
       Accounts payable 
1,447
1,508
645
434
380
536
524
481
437
531
634
650
0
526
526
424
392
361
398
567
618
401
395
486
398
385
219
21938539848639540161856739836139242452652606506345314374815245363804346451,5081,447
       Other Current Liabilities 
0
0
0
0
109
0
0
528
15
14
14
14
0
0
0
0
0
77
0
316
85
0
0
0
0
0
0
000000853160770000014141415528001090000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55
296
276
256
234
211
188
164
148
132
115
97
9711513214816418821123425627629655000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
-331
-390
-410
0
0
0
76
353
353
335
316
296
276
256
208
194
179
164
16417919420825627629631633535335376000-410-390-331000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
276
0
0
211
0
0
0
0
0
0
0000002110027600000000000000000
       Deferred Long Term Liability 
0
0
218
188
15
15
15
15
3
3
3
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000003331515151518821800
> Total Stockholder Equity
12,486
10,809
6,909
8,469
483
-184
-273
-582
-82
-712
-1,192
-1,285
0
-523
-523
527
3,562
3,151
2,191
1,338
471
727
1,039
333
599
890
514
5148905993331,0397274711,3382,1913,1513,562527-523-5230-1,285-1,192-712-82-582-273-1844838,4696,90910,80912,486
   Common Stock
1
1
1
2
2
2
2
2
2
2
2
2
0
0
0
4
4
4
4
4
4
0
0
0
0
0
0
000000444444000222222222111
   Retained Earnings Total Equity000000-28,492-27,6210-25,80500000000000000000
   Accumulated Other Comprehensive Income 000000000000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
28,952
0
28,954
28,959
0
0
0
0
0
0
00000028,95928,954028,95200000000000000000
   Treasury Stock000000000000000000000000000
   Other Stockholders Equity 000000000000000000000000000



6.3. Balance Sheets

Currency in USD. All numbers in thousands.




6.4. Cash Flows

Currency in USD. All numbers in thousands.




6.5. Income Statements

Currency in USD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,365
Cost of Revenue-303
Gross Profit1,0621,062
 
Operating Income (+$)
Gross Profit1,062
Operating Expense-3,823
Operating Income-2,458-2,761
 
Operating Expense (+$)
Research Development0
Selling General Administrative3,520
Selling And Marketing Expenses0
Operating Expense3,8233,520
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-2,458
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-2,324-2,592
EBIT - interestExpense = 0
-2,324
-2,324
Interest Expense0
Earnings Before Interest and Taxes (EBIT)0-2,324
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-2,324
Tax Provision-0
Net Income From Continuing Ops-2,324-2,324
Net Income-2,324
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1340
 

Technical Analysis of Nuo Therapeutics Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Nuo Therapeutics Inc. The general trend of Nuo Therapeutics Inc is BULLISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Nuo Therapeutics Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (85.7%) Bearish trend (-85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Nuo Therapeutics Inc Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Nuo Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.67 < 1.75 < 1.76.

The bearish price targets are: 1.27 > 1.27 > 1.2.

Know someone who trades $AURX? Share this with them.πŸ‘‡

Nuo Therapeutics Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Nuo Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 13/14.
The longshort score for the Moving Averages is 12/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Nuo Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Nuo Therapeutics Inc. The current macd is 0.0511017.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nuo Therapeutics Inc price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Nuo Therapeutics Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Nuo Therapeutics Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Nuo Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartNuo Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Nuo Therapeutics Inc. The current adx is 19.66.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Nuo Therapeutics Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Nuo Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Nuo Therapeutics Inc. The current sar is 1.19.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Nuo Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Nuo Therapeutics Inc. The current rsi is 58.94. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Nuo Therapeutics Inc Daily Relative Strength Index (RSI) ChartNuo Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Nuo Therapeutics Inc. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Nuo Therapeutics Inc price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Nuo Therapeutics Inc Daily Stochastic Oscillator ChartNuo Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Nuo Therapeutics Inc. The current cci is 88.36.

Nuo Therapeutics Inc Daily Commodity Channel Index (CCI) ChartNuo Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Nuo Therapeutics Inc. The current cmo is 20.81.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Nuo Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartNuo Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Nuo Therapeutics Inc. The current willr is -4.16666667.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Nuo Therapeutics Inc Daily Williams %R ChartNuo Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Nuo Therapeutics Inc.

Nuo Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Nuo Therapeutics Inc. The current atr is 0.11477029.

Nuo Therapeutics Inc Daily Average True Range (ATR) ChartNuo Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Nuo Therapeutics Inc. The current obv is -512,676.

Nuo Therapeutics Inc Daily On-Balance Volume (OBV) ChartNuo Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Nuo Therapeutics Inc. The current mfi is 76.55.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Nuo Therapeutics Inc Daily Money Flow Index (MFI) ChartNuo Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Nuo Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-01-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-22MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-01-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-01-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-02-12STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-14ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-25STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-06WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-26MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-03-27DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-28WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-07STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-08MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-04-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-04-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Nuo Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Nuo Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5058.943
Ma 20Greater thanMa 501.540
Ma 50Greater thanMa 1001.413
Ma 100Greater thanMa 2001.418
OpenGreater thanClose1.600
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Nuo Therapeutics Inc with someone you think should read this too:
  • Are you bullish or bearish on Nuo Therapeutics Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Nuo Therapeutics Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Nuo Therapeutics Inc

I send you an email if I find something interesting about Nuo Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Nuo Therapeutics Inc.

Receive notifications about Nuo Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.